Skip to main content

Ascend Wellness Holdings, Inc.

Data quality: 100%
AAWH
OTC Manufacturing Chemicals
$0.48
▲ $0.04 (9.59%)
Mkt Cap: 97.09 M
Price
$0.48
Mkt Cap
97.09 M
Day Range
$0.44 — $0.47
52-Week Range
$0.26 — $1.20
Volume
103,146
Open $0.47
50D / 200D Avg
$0.54
10.88% below
50D / 200D Avg
$0.60
20.19% below

Quick Summary

Key Takeaways

Revenue grew 10.78% annually over 5 years — strong growth
Generating 12.04 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 21.65%
Capital efficient — spends only 5.20% of revenue on capex

Growth

Revenue Growth (5Y)
10.78%
Above sector avg (9.35%)
Revenue (1Y)-10.87%
Earnings (1Y)N/A
FCF Growth (3Y)-51.44%

Quality

Return on Equity
-812.71%
Below sector avg (-51.02%)
ROIC-1.67%
Net Margin-23.61%
Op. Margin-3.40%

Safety

Debt / Equity
N/A
Current Ratio2.18
Interest Coverage-0.33

Valuation

PE (TTM)
-0.82
Above sector avg (-1.98)
P/B Ratio55.32
EV/EBITDA0.17
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -0.8 -2.0
P/B 55.3 5.1
ROE % -812.7 -51.0
Net Margin % -23.6 -150.2
Rev Growth 5Y % 10.8 9.3
D/E 0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y) -10.87% Revenue Growth (3Y) -1.75%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 10.78% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 500.58 M Net Income (TTM) -118.19 M
ROE -812.71% ROA -13.10%
Gross Margin 33.90% Operating Margin -3.40%
Net Margin -23.61% Free Cash Flow (TTM) 12.04 M
ROIC -1.67% FCF Growth (3Y) -51.44%
Safety
Debt / Equity N/A Current Ratio 2.18
Interest Coverage -0.33 Asset Turnover 0.55
Working Capital 113.21 M Tangible Book Value -262.89 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.82 Forward P/E N/A
P/B Ratio 55.32 P/S Ratio 0.19
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 0.17 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 12.41%
Market Cap 97.09 M Enterprise Value 9.82 M
Per Share
EPS (Diluted TTM) -0.58 Revenue / Share 2.47
FCF / Share 0.06 OCF / Share 0.19
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 5.20% FCF Conversion -10.19%
SBC-Adj. FCF 10.29 M Growth Momentum -21.65

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 500.58 M 561.60 M 518.59 M 405.93 M 332.38 M
Net Income -118.19 M -84.99 M -48.21 M -80.90 M -122.66 M
EPS (Diluted) -0.58 -0.40 -0.24 -0.44 -0.82
Gross Profit 169.68 M 184.21 M 155.12 M 134.56 M 135.97 M
Operating Income -17.01 M 4.73 M -3.62 M -7.53 M -17.20 M
EBITDA
R&D Expenses
SG&A Expenses
D&A 73.53 M 66.16 M 58.98 M 37.11 M 22.22 M
Interest Expense 51.29 M 45.26 M 36.98 M 32.44 M 63.99 M
Income Tax 51.38 M 45.17 M 33.45 M 41.69 M 41.72 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 907.93 M 900.43 M 919.55 M 872.16 M 723.44 M
Total Liabilities 954.55 M 828.63 M 776.68 M 708.75 M 546.96 M
Shareholders' Equity -47.44 M 70.98 M 142.87 M 163.42 M 176.48 M
Total Debt 319.52 M 230.85 M
Cash & Equivalents 85.68 M 88.25 M 72.51 M 74.15 M 155.48 M
Current Assets 208.95 M 229.38 M 228.86 M 198.74 M 258.01 M
Current Liabilities 109.01 M 144.54 M 92.69 M 110.95 M 117.40 M